MedTrace Logo

ExoDx Prostate Evaluation in Prior Negative Prostate Biopsy Setting

NCT04357717 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2022-03-31

No results posted yet for this study

Summary

The study is designed to confirm the performance of the ExoDx Prostate test in prior negative biopsy patients now presenting for a repeat prostate biopsy.

Note: ExoDx Prostate test results are collected for correlation to biopsy results and are not disclosed to the physician or study subject.

Conditions

Interventions

DIAGNOSTIC_TEST

ExoDx Prostate

Urine-based biomarker tool to support decision to biopsy in patients with PSA between 2-10ng/ml

Sponsors & Collaborators

  • Exosome Diagnostics, Inc.

    lead INDUSTRY

Eligibility

Min Age
50 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-03-15
Primary Completion
2021-09-01
Completion
2021-09-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04357717 on ClinicalTrials.gov